Directory
>
Scott Rottinghaus
Scott Rottinghaus
Chief Medical Officer | Enanta Pharmaceuticals
United States
Scott Rottinghaus
Summary
Scott Rottinghaus is an accomplished Chief Medical Officer at Enanta Pharmaceuticals, with extensive experience in the pharmaceutical and healthcare industries. He holds an M.D. from Mayo Medical School and has a strong educational background, including an M.Sc. from the University of Cambridge. His expertise spans various fields such as biochemistry, clinical research, and drug development, making him a valuable asset in clinical development and regulatory affairs. Scott has held significant leadership roles at renowned organizations like Alexion Pharmaceuticals and Pfizer, where he led global clinical programs and regulatory submissions. He is passionate about advancing medical science and improving patient outcomes through innovative therapies. In addition to his medical career, he has a unique interest in numismatics, showcasing a diverse set of interests beyond medicine. Scott's commitment to education and mentorship is evident from his role as an Assistant Clinical Professor at Yale University, where he has supervised medical fellows and residents.
Scott Rottinghaus
Work Experience
Chief Medical Officer at
Enanta Pharmaceuticals
August 2022 - Present
Vice President, Head of Clinical Development, Hematology and Nephrology at
Alexion Pharmaceuticals, Inc.
August 2020 - August 2022
Assistant Clinical Professor of Medicine at
Yale University Press
January 2008 - August 2020
VP at
Alexion Pharmaceuticals, Inc.
February 2019 - August 2020
VP, Global Medicine Team Leader at
Alexion Pharmaceuticals, Inc.
February 2019 - August 2020
Executive Director at
Alexion Pharmaceuticals, Inc.
November 2015 - February 2019
Senior Director at
Pfizer, Inc.
August 2007 - October 2015
Governor at
American Numismatic Association
August 2009 - August 2015
Attending Physician at
Birmingham VA Medical Center
October 2004 - July 2007
Fellow in Infectious Diseases at
University of Alabama At Birmingham
July 2004 - June 2007
Resident in Internal Medicine at
Mayo Clinic
January 2001 - January 2004
Scott Rottinghaus
Education
Mayo Medical School, M.D.
January 1997 - January 2001
University of Cambridge, M.Sc.
January 1995 - January 1997
Kansas State University, B.A., B.S.
January 1991 - January 1995
Frequently Asked Questions about Scott Rottinghaus
What is Scott Rottinghaus email address?
Scott Rottinghaus's primary email address is *****************@mayo.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Scott Rottinghaus work for?
Scott Rottinghaus is a Chief Medical Officer at Enanta Pharmaceuticals, a company specializing in Commercial physical research.
Where Scott Rottinghaus graduated from?
Scott Rottinghaus holds a degree in from Mayo Medical School.
How can I directly contact Scott Rottinghaus?
To contact Scott Rottinghaus directly, you can use the email address *****************@mayo.edu. Complete contact information is available upon registration with Muraena.
Who is Scott Rottinghaus?
Scott Rottinghaus is an accomplished Chief Medical Officer at Enanta Pharmaceuticals, with extensive experience in the pharmaceutical and healthcare industries. He holds an M.D. from Mayo Medical School and has a strong educational background, including an M.Sc. from the University of Cambridge. His expertise spans various fields such as biochemistry, clinical research, and drug development, making him a valuable asset in clinical development and regulatory affairs. Scott has held significant leadership roles at renowned organizations like Alexion Pharmaceuticals and Pfizer, where he led global clinical programs and regulatory submissions. He is passionate about advancing medical science and improving patient outcomes through innovative therapies. In addition to his medical career, he has a unique interest in numismatics, showcasing a diverse set of interests beyond medicine. Scott's commitment to education and mentorship is evident from his role as an Assistant Clinical Professor at Yale University, where he has supervised medical fellows and residents.
Scott`s contact details
*****************@mayo.edu
*****************@yale.edu
************@money.org
*****************@pfizer.com
************@uab.edu
*****************@alexion.com
************@enanta.com
Colleagues
Vice President of Chemistry at Enanta Pharmaceuticals
Chief Financial Officer
Vice President, CMC
Chief Business Officer
Chief Product Strategy Officer
Vice President, DMPK & Bioanalysis
Executive Director, Contracts Administration
Executive Director of Accounting, Controller
Vice President, Toxicology
Vice President of DMPK and Bioanalysis